Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Targeting Multiple Myeloma (MM) Life Science
Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing Life Science
CANbridge Pharmaceuticals and GC Pharma Announce Greater China Licensing Agreement for Hunterase™ for Hunter Syndrome Life Science
Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders Life Science
Schrödinger Closes $85 Million Financing to Advance Computational Platform and Expand Drug Discovery Pipeline Life Science
OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology Life Science
